Normative QEEG/ERP Data for Healthy Volunteers
Status unconfirmed
Conditions studied: Healthy
In brief
Many scientific papers have reported that ERP and QEEG biomarkers can be useful in the evaluation of neurological and psychiatric disorders. A study previously conducted with the COGNISION® system has shown how data collected with the system could help detect cognitive deficits in elderly individuals with probable early Alzheimer's disease (Cecchi et al., 2015). Furthermore, normative ranges for ERP and QEEG parameters are sensitive to subject age (see for example van Dinteren et al., 2014). This study will use advanced EEG techniques to measure brain function among healthy adults ages 20 through 59 to use as reference data to compare against individuals that suffer from neurological and psychiatric disorders. QEEG and ERP parameters from the current study will compliment previously collected normative data in healthy subjects 60 years of age and older (Cecchi et al., 2015).
Key facts
- Study ID
- NCT05869032
- Run by
- Neuronetrix, Inc.
- People needed
- 80
- Starts
- 2023-05-22
- Expected to finish
- 2024-09-30
- Last updated by the study team
- 2024-03-29
Who can join
Age: 20 and older, up to 59. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Male and female volunteers 20-59 years of age, inclusive.
- Willingness and ability to provide 1 form of identification with picture.
- Willingness and ability to provide to understand the requirements of the study, provide written informed consent, and abide by the study procedures.
- Fluency in English, even if English is not the primary language.
- Ability to tolerate the electrode cap for the duration of the testing session.
- Subject has not been enrolled or actively participating in another clinical study 4 weeks prior to testing.
You may not qualify if…
- History of neurological and/or psychiatric disorders:
- Diseases of the Dementia type (i.e. Alzheimer's Disease, Vascular Dementia, Parkinson's Disease Dementia etc.)
- Epileptic seizures
- Bipolar Disorder
- Autism Spectrum Disorder
- Depression
- Brain tumor(s)
- Multiple Sclerosis
- Schizophrenia or Schizoaffective Disorder
- Stroke (ischemic or hemorrhagic)
- Traumatic Brain Injury
- Current Drug or Alcohol Abuse
- Diagnosis with HIV/AIDS
- Inability to detect a 1000Hz tone at 40dB in either ear.
- Recent (24 hours) use of medications known to affect QEEG/ERP (cannabinoids, sleep aides, benzodiazepines, opiates/opioids, amphetamines, or barbiturates).
- Recent (day of study) use of energy drinks, including pre-workout drinks and over the counter energy supplements and nootropics.
- Caffeine, alcohol, or products containing nicotine within 1 hour of testing.
- Known allergy to latex.
- Any impairment, activity, or situation that, in the judgment of the study Sponsor, would prevent satisfactory completion of the study protocol.
Where it is running
- Cognision — Louisville, Kentucky, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.